This leads to different subtypes of GBS called: acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axonal neuropathy (AMAN), respectively. Lingering questions.

Patients with Guillain- Barré syndrome (GBS) face a rare and heterogeneous disorder of the peripheral nervous system that is often triggered by preceding infections and causes severe muscle weakness.

Overall, the work of the research team offers novel insights into our understanding of GBS, opening avenues for further investigations on larger patient groups to decipher immune mechanisms in ...

The FDA issued a safety communication that warns about possible Guillain-Barré syndrome (GBS) with respiratory syncytial virus (RSV) vaccines manufactured by Pfizer (Abrysvo) and GSK (Arexvy ...

Guillain-Barré Syndrome (GBS) is a rare autoimmune disorder where the immune system attacks peripheral nerves, causing weakness, tingling, and sometimes paralysis. It often follows infections ...

Most cases (about 75%) have a trigger that occurs about four weeks prior to their attack of GBS. A respiratory infection (such as influenza) is most common, followed by gastroenteritis.

For example, while it is thought that there is a small increased risk of developing GBS after flu vaccination — among 1 million people who get vaccinated, there may be one or two more cases than ...